ALDX
NASDAQ
$1.75
Aldeyra Therapeutics Inc (ALDX)
Aldeyra Therapeutics, Inc., a biotechnology company, develops and markets drugs for immune-mediated systemic and eye diseases. The company is headquartered in Lexington, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $7.17 (+309.71%)
Market Cap
$116M
Free Cash Flow Yield
-22.44%
Beta (5Y)
1.35
Price Chart
Valuation
Market Cap$116M
P/B2.75
Profitability
EBITDA-$28M
EPS-$0.46
Financial Health
Debt-to-Equity36.3%
Free Cash Flow Yield-22.44%
Growth & Risk
EPS 5Y CAGR-15.26%
FCF 5Y CAGR-6.11%
Beta (5Y)1.35
Sharpe Ratio-0.23